Delivery Order SPE2DB24D3013-SPE2DB25FFFMW

Award Date 10/7/24
Potential Completion Date 10/8/24
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order with a ceiling value of $4,266.70, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product, with a completion date of September 19, 2024. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,896.72 firm fixed-price delivery order is for the supply of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The contract has an ultimate completion date of November 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, a delivery order worth $1,080.06, is for the supply of 120 count capsules of the medication Mesalamine Extended Release 0.375 gram. The contract has a completion date of September 10, 2024 and is a firm fixed-price arrangement. Amerisourcebergen, through its Corporate Office Division,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,594.32 Firm Fixed Price delivery order is for the supply of 4566550847 MESALAMINE DR 1.2 GM TABLET 120S. The contract has an ultimate completion date of November 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,163.57 Firm Fixed Price Delivery Order contract covers the supply of MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mesalamine ER 0.375 gram capsules. The contract is a Delivery Order valued at $15,169.44 with a completion date of August 20, 2024. The contract is not set aside and is a Firm Fixed Price agreement. Amerisourcebergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and...
This federal contract award is for the delivery of MESALAMINE ER 0.375 GRAM CAP 120S to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,984.53 and is a Firm Fixed Price Delivery Order with an ultimate completion date of October 17, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of MESALAMINE ER 0.375 GRAM CAP 120S, a prescription medication. The order is valued at $3,642.70 and has a firm fixed price. The period of performance runs through October 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,028.77 under the company's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the delivery of 4563849930 MESALAMINE DR 400 MG CAPSULE 180S, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen's IDC with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mesalamine delayed-release capsules. The $1,344.69 Firm Fixed Price Delivery Order contract has a completion date of September 18, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a wide range of medical commodities...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFFMW
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $5,464.86 firm-fixed-price delivery order is for the supply of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The contract has an ultimate completion date of October 8, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and other federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical for a comprehensive range of medical commodities. The company also holds a $750,000 IDC with the Department of Justice Federal Bureau of Investigation for pharmaceutical and medical products. This award is not designated as a set-aside contract.

Generated 1/6/25, 12:27 PM